Search

There are so many things that you provide, for which I am thankful for. When you live with a chronic illness, life can become overwhelming and tiring. You provide me and other people living with MS with so many services that can help make our lives that much easier. In February you gave me the opportunity to attend the younger persons respite stay in the MS Care Centre in Bushy Park. I was very apprehensive about attending as my mobility is now very good and my MS is more of an invisible disability as of now. Although I was in two minds about going, I am so happy I did as it was the best week of my life. 

Call for participants! 

MS Ireland is pleased to present on Thursday, 26th October at 8pm our next Unspeakable Bits webinar titled, Disclosure.

We held our Annual General Meeting on Saturday, 16th September 2023 via Zoom with members of MS Ireland logging in throughout the country.

Below are the main updates from the meeting.

We held our Annual General Meeting on Saturday, 16th September 2023 via Zoom with members of MS Ireland logging in throughout the country.

Below are the main updates from the meeting.

Sean Martin is a chartered accountant and a partner in PwC.  He has over 15 years experience advising companies on acquisitions, disposals and valuations. He has worked with many of Ireland's largest public and private companies.

He lives in Dublin with his wife and two girls. He was diagnosed with MS in 2015.

Sean Martin is a chartered accountant and a partner in PwC.  He has over 15 years experience advising companies on acquisitions, disposals and valuations. He has worked with many of Ireland's largest public and private companies.

He lives in Dublin with his wife and two girls. He was diagnosed with MS in 2015.

In a significant development, the HSE has announced a Managed Access Program for Sativex, an anti-spasticity medication which may be of benefit to those who experience MS-related spasticity but for whom other anti-spasticity medications have not been successful. 

Board Member

The Multiple Sclerosis International Federation (MSIF) has released a one-page information sheet highlighting the relationship between Epstein-Barr virus (EBV) and multiple sclerosis (MS). EBV, a prevalent virus affecting up to 95% of the global population, has long been a subject of interest in MS research.